HS-173, a selective PI3K inhibitor, induces cell death in head and neck squamous cell carcinoma cell lines.
CONCLUSION: The selective PI3K inhibitor HS-173 is a potent chemosensitizing and also radiosensitizing drug in treatment of HNSCC cell lines and could be an effective treatment in PI3K-mutated HNSCC.
PMID: 32876741 [PubMed - as supplied by publisher]
Source: Wiener Klinische Wochenschrift - Category: General Medicine Authors: Foki E, Stanisz I, Kadletz L, Kotowski U, Seemann R, Schmid R, Heiduschka G Tags: Wien Klin Wochenschr Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | General Medicine | Head and Neck Cancer | HNSCC | Lung Cancer | Non-Small Cell Lung Cancer | Pancreas | Pancreatic Cancer | Skin Cancer | Squamous Cell Carcinoma | Study
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024